Over the past decade, several observational studies have demonstrated that increased inflammatory markers (elevated WBC, tumor necrosis factor-α, interleukin-6, and C-reactive protein [CRP]) and lymphopenia are associated with both cardiovascular and all-cause mortality among hemodialysis patients.2 This evidence concerns the gene CRP and lymphopenia.